Application 213321
- Type
- ANDA
- Sponsor
- GRANULES PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | 300MG;50MG;40MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70010-044 | Butalbita,Acetaminophen and Caffeine | Butalbita,Acetaminophen and Caffeine | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-044 | Butalbita,Acetaminophen and Caffeine | Butalbita,Acetaminophen and Caffeine | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-044 | Butalbita,Acetaminophen and Caffeine | Butalbita,Acetaminophen and Caffeine | Granules Pharmaceuticals Inc. | ANDA | Current |
| 80425-0215 | Butalbital/Acetaminophen/Caffeine | Butalbital/Acetaminophen/Caffeine | Advanced Rx Pharmacy of Tennessee, LLC | ANDA | Current |